Procjena anthelmintičke učinkovitosti pripravaka albendazola i ivermektina u magaraca u Darfuru u Sudanu

The therapeutic efficacies of albendazole and ivermectin drench formulation at the manufacturer’s recommended dose were evaluated in a controlled trial in Nyala town, South Darfur State, Sudan. The study involved 24 donkeys naturally infected with gastrointestinal nematodes; they were divided into four groups of equal size. Albendazole was administered orally once at a dose rate of 10 mg/kg body mass, or twice, 14 days apart at dose rate of 10 mg/kg body mass. Ivermectin was administered orally as a single dose at 200 μg/kg body mass. Treatment efficacy was based on the mean faecal egg count reduction 14 days post treatment. A faecal egg count reduction of 100% was found after treatment with albendazole and ivermectin. In addition efficacy percentages of albendazole and ivermectin against immature and adult nematodes were as follows: Trichostrongylus axei 67.09% and 100%, Parascaris equorum 100% and 100%, Oxyuris equi 100% and 100%, Strongylus sp. 98.4% and 100%; and small strongyles 100% and 100%. Albendazole single and twice and ivermectin with the single dose showed moderate efficacy (33%, 59.08% and 62.71%, respectively) against larvae found in the cranial mesenteric artery aneurisms. No adverse reactions were observed in treated donkeys during the experiment period.Učinkovitost pripravaka albendazola i ivermektina u preporučenoj dozi istražena je u kontroliranom pokusu provedenom na magarcima u gradu Nyala u južnom Darfuru u Sudanu. Istraživanje je obuhvatilo 24 magarca prirodno invadirana želučanocrijevnim oblićima. Magarci su bili ravnomjerno raspoređeni u četiri skupine te peroralno liječeni albendazolom u dozi od 10 mg/kg tjelesne mase jednokratno ili dvokratno u razmaku od dva tjedna. Ivermektinom su liječeni peroralno i to jednokratno u dozi od 200 mg/kg tjelesne mase. Ljekovit učinak bio je određen na temelju smanjenja broja jaja u izmetu dva tjedna nakon liječenja. Dokazano je bilo 100%-tno smanjenje broja jaja nakon liječenja obama pripravcima. Učinkovitost je bila dokazana i postmortalnom parazitološkom pretragom i to prebrojavanjem nezrelih i odraslih oblića. U liječenih životinja ustanovljeno je 67,9% manje nezrelih te 100% manje odraslih oblića Trichostrongylus axei. Stopostotna učinkovitost bila je dokazana za nezrele i za zrele obliće Parascaris equorum, Oxyuris equi te male strongilide. Nešto manja učinkovitost (98,4%) bila je dokazana za nezrele obliće Strongylus sp. Kombinacija jednokratnoga i dvokratnoga davanja albendazola s jednokratnim davanjem ivermektina pokazala je prosječno dobru učinkovitost (33%, 59,08% i 62,71%) protiv ličinki u aneurizmama na području kranijalne mezenterijske arterije. U magaraca nisu bile primijećene nikakve nuspojave nakon primjene lijekova

Procjena anthelmintičke učinkovitosti pripravaka albendazola i ivermektina u magaraca u Darfuru u Sudanu

The therapeutic efficacies of albendazole and ivermectin drench formulation at the manufacturer’s recommended dose were evaluated in a controlled trial in Nyala town, South Darfur State, Sudan. The study involved 24 donkeys naturally infected with gastrointestinal nematodes; they were divided into four groups of equal size. Albendazole was administered orally once at a dose rate of 10 mg/kg body mass, or twice, 14 days apart at dose rate of 10 mg/kg body mass. Ivermectin was administered orally as a single dose at 200 μg/kg body mass. Treatment efficacy was based on the mean faecal egg count reduction 14 days post treatment. A faecal egg count reduction of 100% was found after treatment with albendazole and ivermectin. In addition efficacy percentages of albendazole and ivermectin against immature and adult nematodes were as follows: Trichostrongylus axei 67.09% and 100%, Parascaris equorum 100% and 100%, Oxyuris equi 100% and 100%, Strongylus sp. 98.4% and 100%; and small strongyles 100% and 100%. Albendazole single and twice and ivermectin with the single dose showed moderate efficacy (33%, 59.08% and 62.71%, respectively) against larvae found in the cranial mesenteric artery aneurisms. No adverse reactions were observed in treated donkeys during the experiment period.Učinkovitost pripravaka albendazola i ivermektina u preporučenoj dozi istražena je u kontroliranom pokusu provedenom na magarcima u gradu Nyala u južnom Darfuru u Sudanu. Istraživanje je obuhvatilo 24 magarca prirodno invadirana želučanocrijevnim oblićima. Magarci su bili ravnomjerno raspoređeni u četiri skupine te peroralno liječeni albendazolom u dozi od 10 mg/kg tjelesne mase jednokratno ili dvokratno u razmaku od dva tjedna. Ivermektinom su liječeni peroralno i to jednokratno u dozi od 200 mg/kg tjelesne mase. Ljekovit učinak bio je određen na temelju smanjenja broja jaja u izmetu dva tjedna nakon liječenja. Dokazano je bilo 100%-tno smanjenje broja jaja nakon liječenja obama pripravcima. Učinkovitost je bila dokazana i postmortalnom parazitološkom pretragom i to prebrojavanjem nezrelih i odraslih oblića. U liječenih životinja ustanovljeno je 67,9% manje nezrelih te 100% manje odraslih oblića Trichostrongylus axei. Stopostotna učinkovitost bila je dokazana za nezrele i za zrele obliće Parascaris equorum, Oxyuris equi te male strongilide. Nešto manja učinkovitost (98,4%) bila je dokazana za nezrele obliće Strongylus sp. Kombinacija jednokratnoga i dvokratnoga davanja albendazola s jednokratnim davanjem ivermektina pokazala je prosječno dobru učinkovitost (33%, 59,08% i 62,71%) protiv ličinki u aneurizmama na području kranijalne mezenterijske arterije. U magaraca nisu bile primijećene nikakve nuspojave nakon primjene lijekova